Download File Game

THE DEAD Beginning v1 16 MOD APK Data is Here ! LATEST

THE DEAD: Beginning v1.16 MOD

Ever ready to experience the most terrible zombie!
Zombie Horde you will be able to avoid attacks? Grab your guns and wave after wave of the undead rid the world follow us as absurd heroes. How long will you survive?> More maps are coming!

•  New amazing 3D touch control system
•  Loads & loads of weapons
• Tons of useful items to help you survive, like turrets & grenades
• NextGenFULL 3D premiere quality graphics Highly addictive gameplay
• New maps added frequently
•  Level up and get access to new weapons, items, characters, upgrades & maps
• Perform challenges and reap the rewards
• Challenging boss levels
• Superior sound and music Individual storylines and zombies on each mapStory - Cabin
  With the Living Dead overrun, the young family a safe haven, a refuge from the city seeks to cabin in the mountains. But they are fresh out of luck. Zombie Infestation reached the outpost is peaceful. Now you can protect your wife and daughter to have to do all you can.
  Story - Club
  Moscow underworld is a rough and scary place, but it is home to a man Michaeli Vronsky. Brought to the streets alone, fighting for food, medicine and to follow it immediately with the sale, to survive turned to petty thefts. Moscow tonight Something is wrong, and it is going down to the local club is not related to the transaction, it is something else, and that is unfamiliar to Michaeli is an ill wind.

 

THE DEAD: Beginning v1.16 MOD

THE DEAD: Beginning v1.16 MOD

THE DEAD: Beginning v1.16 MOD

Downloads

THE DEAD: Beginning v1.16 MOD Apk/Mirror
THE DEAD: Beginning v1.16 OBB Data(218 MB)

Go to link for download

Its a gas! The Nobel Memorial Prize in Economics

Scientific Cat-nundrums

This week, contracts won a Nobel prize. Or rather, economists Oliver Hart and Bengt Holmström were awarded the Nobel prize in economics for their work on contracts. Their studies have enhanced our understanding of incentives by examining how contracts affect relationships between employers, employees, societies and governments.  The application of incentives to IP is broad - the innovation/social contract approach to IP, patents as performance indicators in employment contracts, and, the bread-and-butter of IP, licensing contracts.

Eyes on the Prize
First of all, a bit of background. If you are an economist who supports the selection, i.e. that the winning economists work supports your own work, then you must praise the Nobel committees choice and the prestige of the prize. If you are not, then you must highlight that the economics prize is not a true Nobel prize, as it is comes from the Swedish National Bank, and therefore is not particularly impressive. Either way, one must be careful not to be too enthusiastic about a fellow economists success, lest it be taken for indication of an emotional imbalance.

Second of all, some tips if you, dear reader, are interested in winning said prize. First of all, start early and live long so that your genius has time to be recognised. Second of all, be male. Only one woman, Elinor Ostrom, has received the prize. Third, make sure you are somehow Western, and ideally American. Fourth, become at expert at posing for photos in front of books. Finally, surprisingly, remember you dont actually have to be an economist to win; John Nash, who had the gall to be a mathematician, won in 1994.  Things really are going to pot.

Contract theories
Hart and Holmström have won the prize because their names both start with H they developed complementary contract theories. Holmström began by studying trade-offs in contracts. The classic illustration is insurance, which combines both information asymmetry, where parties in a contract do not have the same information, and moral hazard, where a party may engage in riskier behaviour because the risk is shared. For example, a health insurer has less information about the insureds lifestyle than the insured.  [Merpels insurer doesnt know how much catnip she consumes.] Once insured, the insured shares potential costs with the insurer, and will engage in riskier behaviour. [Merpel has taken up parkour, because she wont have to pay for the hospital bills.]

Hart built further on this theory by examining the incompleteness of contracts. No contract can possibly foresee every outcome and consequence of incentives. He argued that property rights help mitigate this, as they place the burden of decision making on those with the property - and hence those with a stake in the unforeseen outcomes. Harts recent work on prisons illustrates this; summarised by The Economist: "In publicly owned prisons, managers might underinvest in quality-improving measures, but private owners face too strong an incentive to cut costs, leading to conditions for prisoners that are worse than those in public prisons." These incentives apply to most government services.  A privatised patent-granting body would have different incentives than a public body (think of those renewal fee$!)

Contracts and IP
Readers of Katonomics will be familiar with economists focus on the incentives-to-innovate theory of IP. This is often known as the Social Contract (covered previously here), in which IP is a contract between innovators and society; the monopoly protection of IP provides a long-term incentive to innovate. Society cannot foresee (information asymmetry) the value of each potential innovation, so all innovators are granted the same level of protection. Assigning the property right to the innovator incentivises innovation as the innovator has a stake in the outcome and the IP system as a whole.

Trophies, by R. Oxley, CC

A goal of researcher employment contracts is to align firms innovation needs with employee incentives. Patents are sometimes used as a metric of performance. There is a large body of economic analysis on the use of patents as a measure of innovation; the general conclusion of which is that patents measure patents, not innovation. More specifically, Harhoff and Hoisl (2007) examine German policies via a large survey, and find that, unsurprisingly, more valuable patents are associated with higher levels of employee compensation.  Baker (1992) models scientists salaries as entirely dependent on the number of patents they produce (a problematic assumption.)  In his model, scientists are unduly incentivised to work on "easy" patents and therefore the employer reduces the per-patent payment to avoid overpaying. Japan has recently changed its approach to patents, making it easier for employers to own patents generated by employees.

Finally, licensing contracts enjoy a never-ending analysis of incentives and clauses. The primary job of lawyers negotiating and drafting such contracts is to align the incentives in the contract with the needs of the client.  While researching the biotech sector in 2007, I came across an interesting case. My interviewee had exclusively licensed a product on a royalty basis. The licensee instead marketed a competing product, leaving the licensor without royalties.  The contract had been used to eliminate competition from the market, and failed to align the parties incentives. Another anecdote is the use by wealthy Multi-national Companies (MNC) of reversion clauses when partnering with companies in developing countries. The MNC engages in joint research and market expansion, then deliberately causes the project to fail in order to trigger the reversion clause. Both background and foreground IP, as per the contract, revert to the MNC. Its a cheap way to expand internationally.

I invite readers to tell their stories of the odd quirks of licensing contracts in the comments.  In the meantime, Im off to work with Merpel on contract incentives of catnip producers. Fingers crossed for a Nobel!

Go to link for download

THE KING OF FIGHTERS ’97 v1 2 APK Latest

THE KING OF FIGHTERS ’97

Revisit this fighting gem, by playing one of its legendary (and sometimes hidden) teams, and behold the numerous endings the game has to offer!
Put an end to the evil Orochi’s resurrection scheme, and finally settle the score between Kyo Kusanagi and Iori Yagami!

Features

• 35 playable characters!
• Play as SNK’s iconic fighters such as Kyo Kusanagi and Terry Bogard, and try to master the infamous “New
• Face Team” or the “KOF ’97 Special Team”!
• The NEO GEO version’s hidden characters are now available directly on the character select screen so you can
• easily crush your opponent using Orochi Iori or Orochi Leona!
• Experience for the first time in the series the “Affinity System”, and to select the members of your team
• according to their affinity, and enjoy their pre-match interactions!
• 2 modes to improve the game’s depth!
• KOF ’97 uses 2 differents gameplay modes: EXTRA and ADVANCED! Master the system that fits you the best
• and burn your rivals down!

How to Install ?

1. Download The Apk given below
2. Install normally
3. Done.Enjoy !!

Downloads & Links

THE KING OF FIGHTERS ’97 v1.2 APK (7.0 MB) | Mirrors
THE KING OF FIGHTERS ’97 v1.2 Data (50.0 MB) | Mirrors

Go to link for download

Servier successful before Henderson J in introducing defence based on the Department of Healths prescribing reimbursement practices

We are now into the Autumn season and the Michaelmas term, which means an influx of new court judgments.  This author was delighted to stumble upon the latest decision in the intriguing litigation between Secretary of State for Health and Others v Servier when browsing through the recent list of Chancery decisions ([2016] EWHC 366 (Ch)).  This long running saga concerns the thorny intersection of patent rights and antitrust claims, and now - an added attraction in the form of the governments role in providing prescribing guidance to healthcare professionals, and making changes to the NHS drugs tariff for reimbursement.

The IPKat was rather less enthused by the decision.

Background

Servier are the suppliers of the original, branded version of Perindopril, which was supplied in the UK under the brand name "Coversyl". Perindopril is an angiotensin-converting enzyme inhibitor ("ACE inhibitor") which is used in the treatment of hypertension and congestive heart failure. Patent EP 1 296 947 (the 947 Patent) was a patent for a particular crystalline form of Perindopril – the alpha crystalline form - which Servier applied for in 2001, and which was in 2007 held to be invalid for lack of novelty and obviousness in Les Laboratories Servier v Apotex Inc ([2007] EWHC 1538 (Pat), upheld by the Court of Appeal [2008] EWCA Civ 445.) In those proceedings it was held that one of Serviers pre-existing process patents, EP 0 308 341, led to the production of the alpha form as its inevitable result.

Following a decision of the European Commission, the Secretary of State for Health ("DoH") has brought a claim in the High Court of England & Wales alleging that Servier tortiuously interfered with the DoHs economic interests by unlawful means in that it procured, defended and enforced the 947 Patent.  The DoH also alleges breach of Article 102 of the TFEU, on the basis that Servier was dominant on the market for the supply of Perindopril or for the supply of ACE inhibitors in the UK between 2011-2007, and that it abused its dominant position.  Further, it claims an infringement of Article 101, on the basis that Servier concluded anti-competitive settlement agreements with various generic suppliers which precluded those companies from challenging the 947 patent, or from supplying generic Perindopril in the UK (i.e. pay for delay). 

Similar legal proceedings have been issued by the Scottish, N Irish, and Welsh health authorities, and the cases have been linked and are proceeding in parallel.

Application to re-amend Defence

This decision concerned an application by Servier to re-amend its Defence, in a form which can be summarised as follows:

1. The Claimant failed to take reasonable steps to encourage switching from the prescription of Perindopril to the prescription of cheaper alternative ACE inhibitors in generic form (the "prescribing argument").  This: (a) results in a failure of the Claimant to mitigate its loss; (b) amounts to contributory negligence in relation to the tortious interference claims; and (c) broke the chain of causation/rendered any damage suffered by the Claimant too remote. 

The DoH opposed this amendment on the basis that it is not reasonable arguable.  The DoHs opposition was motivated by concerns that giving disclosure of all documents formerly held by Primary Care Trusts (predecessors to clinical commissioning groups) in relation to the prescribing argument, and addressing it in witness evidence and at trial would be extremely burdensome and expensive.

2. The Claimant failed to act expeditiously in moving Perindopril into category M (i.e. the generic price category) of the NHS Drug Tariff. This proposed amendment was not challenged by the DoH.

The Scottish, N Irish and Welsh health authorities did not oppose Serviers application to amend.
 
Analysis of the Court

It was common ground that the test for "not reasonably arguable" is the same as the summary judgment standard under Civil Procedure Rule Part 24, namely, whether the amendment has a real as opposed to fanciful prospect of success.  The DoH submitted that there was a fundamental inconsistency between the prescribing argument and the nature of the causes of action. Claims under articles 101 and 102 are aimed at protecting consumers from market power being created artificially or exploited by producers in order to raise prices above competitive levels. It would be incompatible to reduce Serviers liability on the basis that the DoH (essentially the consumer) should never have purchased the product at the inflated price in the first place. 

Henderson J analysed five separate arguments advanced by the DoH for saying that Serviers mitigation defence based on the prescribing argument had no real prospect of success (only the first will be analysed in this report, it being of particular interest). The court noted that the doctrine of mitigation cannot come into play before the relevant breach of contract has occurred.  The issue then was whether the case against Servier involves: (a) allegations of a series of separate infringements of their rights occurring on each occasion when they purchased branded Perindopril; or (b) allegations of certain specific infringements of their rights at specific times which produced a series of losses stemming from those infringements on each occasion that Perindopril was subsequently bought. Ultimately, the issue turned on the form of the DoHs pleading. There was no clearly pleaded foundation for the proposition that each and every supply of Perindopril involved the accrual of a fresh cause of action.  Instead, the claim was framed in the sense that the specific infringements alleged against Servier had the result that generic entry into the market was unlawfully delayed and the consequence that Servier was able to continue charging its normal price for branded Perindopril. The prescribing argument was properly advanced as a failure to mitigate.

The DoH submitted that the prescribing argument could not provide a defence of contributory negligence, because the alleged negligence is not the effective cause of the loss, but merely the occasion for it.  Henderson J noted that this was a highly fact-specific issue which was unlikely to be suitable for summary determination.  It was reasonably arguable that the ongoing levels of purchase at Perindopril at a high price were caused in part by the DoHs conduct in failing to encourage switching to other ACE inhibitors.  Similarly, it is possible that this alleged failure of the DoH amounted to a break in the chain of causation.  In light of the above, Serviers "prescribing argument" defence in its various guises was allowed. 

Comment

So far as this GuestKat is aware, this is the first occasion on which prescribing and reimbursement matters have been raised by way of defence in a claim made by public healthcare authorities against a pharmaceutical company.  The 31 page judgment is a juicy one, and well worth a read for those interested in this area. It is worth remembering that the standard for introducing pleading amendments is a low hurdle, and it remains to be seen whether any of these defences will gain traction with the Court in due course.   

Go to link for download

Galaxy S8 will be a major change without the Home key in front of all the screen

[Abstract] Without the Home button, the front of the phone without any borders, all the screen, the introduction of dual cameras, which is about to bring Galaxy S8 changes.


Samsung in the end how to prepare the cards? Industry is very interested in, the only sure thing is: Galaxy S8 will be a huge change in the hardware. Previous models used older components, but the latest news suggests that Samsung may introduce new features on S8, use the new design, these features and design have not been before, Samsung is actively looking for new components.

From the Samsung partners, electronic components industry, the news leaked, the most noteworthy is the Galaxy S8 hardware will be upgraded. In all the changes in the component, the user experience is the most obvious is completely different display.(Method to Transfer Data Contacts from Samsung to Galaxy S8)

There is no Home key

It is reported that Samsung will remove the Home button, the final button function will be implanted in the back of the glass, or the internal display. Home button can not only return to the main screen, you can also identify the fingerprint. To replace the Home function, Samsung has a variety of technologies to choose from, in the end what is unclear. The end of the Home button means that Samsung can use a new screen, the Galaxy S8 all the front into the screen, which is completely eliminate the border.

Galaxy Note 7 on the left and right is no border, in order to achieve this, Samsung enhanced the arc of the OLED screen. There is news that Samsung will Galaxy S8 upper and lower borders are also eliminated.

All the front is the screen

In order to achieve its goal, Samsung is ready to adopt a screen called "Full Screen", which will cover the front of the entire smart phone, this smart phone is not seen before. From this, smart phones will usher in a huge change. Because the S8 in front of all the screen, so it looks very simple and elegant. In addition, the screen displays pictures and video will be more clear, will have a 3D effect.

Apples move has also attracted peoples attention, the news that Apple is developing full-screen smart phone. This year in September, "New York Times" quoted Apple representative as saying next year will be launched to install full-screen iPhone, Home button will be gone forever.

Rumors can come true is not clear, Apple will launch next year, OLED iPhone, when there will be a clear answer. Apples OLED screen is made by Samsung Display, a subsidiary of Samsung, which specializes in manufacturing displays that play a key role in full-screen displays.

Dual camera how to choose?

Galaxy S8 also may be installed rear dual camera. "Samsung is making a decision to see whether it will be a dual camera or a dual camera, and a dual camera," said a representative from the component industry.



One dual camera with two lenses, one module, two separate cameras with separate modules. One single dual camera cost is relatively low, but manufacturing is very difficult to separate the price of expensive dual cameras, but the production yield is very good.

Samsung believes that dual cameras can improve the quality of photographs. To show the depth of the photo, dual camera is a good choice, it can also make the subject more clearly, so that the background blur. Rumors that Samsungs dual-camera support 16 million pixels and 8 million pixels.

Processor upgrade

Galaxy S8 processor will be used to upgrade. The Foundry Business Team, part of Samsungs Device Solutions LSI division, is preparing to begin production of the Dragon 830 processor, which uses 10-nanometer technology, and the Galaxy S8 will install the 830 processor, the fastest Mass production will begin before the end of the year. Half of the Galaxy S8 will be installed 830, half of the installation Exynos processor.

"Qualcomm has not been able to provide chips to S6 because of its poor performance, and Qualcomm has been forced to reorganize Koreas design engineering department," said a representative from the semiconductor industry. "Why did we offer an application processor to Samsung this year? Nano Xiaolong 820 to the Samsung production, in return, Samsung agreed to install in Galaxy series Xiao Long processor.

As the manufacturing process more advanced, Xiaolong 830 processor performance will be increased, the consumption of electricity will be reduced. Which means that the life time of smart phones will be extended.

Launch time

With Galaxy Note 7 recalls growing, some believe the Galaxy S8 will come out ahead of time, as Samsung can move ahead to the next handset, selling early, rather than pinning its hopes on Galaxy Note 7.

The problem is that if Samsung is really accelerating the progress of the quality defects may occur again. In addition, Galaxy S8 hardware has changed dramatically, to be introduced in the short term is very difficult. For this reason, S8 is likely to be released in February next year, March sales, and the same as the previous model.

"As the Galaxy Note 7 ran into trouble, Samsung seemed to be turning more attention to the development of the Galaxy S8," said an industry representative.

Go to link for download